Results 1 to 3 of 3

Thread: Moderna executives cashing in on COVID-19 vaccine stock speculation, its Israeli CMO nets $35M

  1. #1

    Exclamation Moderna executives cashing in on COVID-19 vaccine stock speculation, its Israeli CMO nets $35M

    "Money time" for these guys with bit of 'plague profiteering' in adavance. There is an old saying that 'Luck is when opportunity meets preparation", these guys must be very lucky.

    July 2, 2020

    How Moderna executives are cashing in on COVID-19 vaccine stock speculation

    Tom Bergin, Robin Respaut
    10 Min Read

    (Reuters) - Biotech firm Moderna Inc could reap tens of billions of dollars in sales and stock appreciation if it wins the race for a COVID-19 vaccine. If it loses, the early-stage company’s value could crash.

    FILE PHOTO: A sign marks the headquarters of Moderna Inc, which is developing a vaccine against the coronavirus disease (COVID-19), in Cambridge, Massachusetts, U.S., May 18, 2020. REUTERS/Brian Snyde

    In the meantime, the firm’s chief executive is pocketing millions of dollars every month by selling shares that have tripled in price on news of Moderna’s development progress, a Reuters analysis of corporate filings shows. The sales - by CEO Stéphane Bancel, his childrens’ trust and companies he owns - amount to about $21 million between January 1 and June 26, including $6 million in May.
    The company’s chief medical officer, Tal Zaks, has cashed out the majority of his available stock and options, netting over $35 million since January, the filings show.
    The lucrative liquidations highlight the unusually powerful incentives for biotech executives to highlight development milestones for drugs that often never get approved or sold, according to interviews with seven executive-compensation experts. Optimistic corporate statements on coronavirus vaccines, they said, could cause investors to overpay for company shares or create false hope among the public and health officials seeking new weapons to fight the pandemic.

    https://www.reuters.com/article/us-h...-idUSKBN2433AH



    Related

    Moderna unveiled encouraging coronavirus vaccine results. Then top execs dumped nearly $30 million of stock
    By Matt Egan and Chris Isidore
    May 22, 2020
    https://www.cnn.com/2020/05/22/inves...les/index.html



  2. Remove this section of ads by registering.
  3. #2
    21st Century fascism at "Warp Speed."
    Chris

    "Government ... does not exist of necessity, but rather by virtue of a tragic, almost comical combination of klutzy, opportunistic terrorism against sitting ducks whom it pretends to shelter, plus our childish phobia of responsibility, praying to be exempted from the hard reality of life on life's terms." Wolf DeVoon

    "...Make America Great Again. I'm interested in making American FREE again. Then the greatness will come automatically."Ron Paul

  4. #3
    I wonder how much profit the Moroccan-born Moncef Slaoui made?!?

    To head Operation Warp Speed (for the fast-track a COVID-19 vaccine), President Donald has appointed Dr. Moncef Slaoui as Chief Adviser and General Gustave Perna as the Chief Operation Officer.

    Moncef Slaoui is the former chairman of GlaxoSmithKline’s vaccines division.
    When he was chairman of GSK’s vaccines division, it developed the malaria vaccine Mosquirix, funded by The Bill and Melinda Gates Foundation.
    GlaxoSmithKline is also working on a COVID-19 vaccine.

    After leaving GSK, Slaoui has taken on executive roles at several other biotech firms, including companies that receive funds to develop a COVID-19 vaccine.
    Moncef Slaoui has earned $490,000 as a board member at Moderna, Inc. that has received part of the billions of dollars bonanza to develop a gene-altering COVID-19 vaccine.
    Slaoui is also a director of the Swiss Lonza Group AG that is working with Moderna on a Covid-19 vaccine.


    Slaoui is also a partner at Medicxi, that invests in pharmaceutical industry, and sits on the board of companies that Medicxi has invested in, including as chairman of the board at biotech medical firm Galvani Bioelectronics.
    Galvani Bioelectronics was started in 2016 with funding from GSK and Google and specialises in bioelectronic “medicines” – implantable electronic devices labelled a new class of “medicines” consisting of miniaturised: https://healthimpactnews.com/2020/tr...itary-advisor/
    Do NOT ever read my posts. Google and Yahoo wouldn’t block them without a very good reason: Google-censors-the-world/page3

    The Order of the Garter rules the world: Order of the Garter and the Carolingian dynasty



Similar Threads

  1. Replies: 28
    Last Post: 06-16-2020, 08:05 PM
  2. Replies: 3
    Last Post: 06-04-2020, 09:02 AM
  3. Replies: 8
    Last Post: 06-03-2020, 09:25 PM
  4. Moderna and the COVID Vaccine: What Kind of Lunacy?
    By PAF in forum U.S. Political News
    Replies: 5
    Last Post: 05-24-2020, 08:50 PM
  5. Replies: 5
    Last Post: 05-21-2020, 02:56 PM

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts
  •